Literature DB >> 26892577

Serum Cholesterol Levels within the High Normal Range Are Associated with Better Cognitive Performance among Chinese Elderly.

Y-B Lv1, Z X Yin, C-L Chei, M S Brasher, J Zhang, V B Kraus, F Qian, X-M Shi, D B Matchar, Y Zeng.   

Abstract

OBJECTIVES: The association between cognitive function and cholesterol levels is poorly understood and inconsistent results exist among the elderly. The purpose of this study is to investigate the association of cholesterol level with cognitive performance among Chinese elderly.
DESIGN: A cross-sectional study was implemented in 2012 and data were analyzed using generalized additive models, linear regression models and logistic regression models.
SETTING: Community-based setting in eight longevity areas in China.
SUBJECTS: A total of 2000 elderly aged 65 years and over (mean 85.8±12.0 years) participated in this study. MEASUREMENTS: Total cholesterol (TC), triglycerides (TG), low density lipoprotein cholesterol (LDL-C) and high density lipoprotein cholesterol (HDL-C) concentration were determined and cognitive impairment was defined as Mini-Mental State Examination (MMSE) score ≤23.
RESULTS: There was a significant positive linear association between TC, TG, LDL-C, HDL-C and MMSE score in linear regression models. Each 1 mmol/L increase in TC, TG, LDL-C and HDL-C corresponded to a decreased risk of cognitive impairment in logistic regression models. Compared with the lowest tertile, the highest tertile of TC, LDL-C and HDL-C had a lower risk of cognitive impairment. The adjusted odds ratios and 95% CI were 0.73(0.62-0.84) for TC, 0.81(0.70-0.94) for LDL-C and 0.81(0.70-0.94) for HDL-C. There was no gender difference in the protective effects of high TC and LDL-C levels on cognitive impairment. However, for high HDL-C levels the effect was only observed in women. High TC, LDL-C and HDL-C levels were associated with lower risk of cognitive impairment in the oldest old (aged 80 and older), but not in the younger elderly (aged 65 to 79 years).
CONCLUSIONS: These findings suggest that cholesterol levels within the high normal range are associated with better cognitive performance in Chinese elderly, specifically in the oldest old. With further validation, low cholesterol may serve a clinical indicator of risk for cognitive impairment in the elderly.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26892577      PMCID: PMC4955538          DOI: 10.1007/s12603-016-0701-6.

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  48 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

Review 3.  Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease?

Authors:  Makoto Michikawa
Journal:  J Neurosci Res       Date:  2003-04-15       Impact factor: 4.164

4.  Towards Deeper Research and Better Policy for Healthy Aging --Using the Unique Data of Chinese Longitudinal Healthy Longevity Survey.

Authors:  Yi Zeng
Journal:  China Economic J       Date:  2012

5.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

6.  Inhibition of cholesterol production but not of nonsterol isoprenoid products induces neuronal cell death.

Authors:  M Michikawa; K Yanagisawa
Journal:  J Neurochem       Date:  1999-06       Impact factor: 5.372

7.  Relationship between plasma lipids and all-cause mortality in nondemented elderly.

Authors:  Nicole Schupf; Rosann Costa; Jose Luchsinger; Ming-Xin Tang; Joseph H Lee; Richard Mayeux
Journal:  J Am Geriatr Soc       Date:  2005-02       Impact factor: 5.562

8.  Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.

Authors:  Fumihiko Yasuno; Satoshi Tanimukai; Megumi Sasaki; Shin Hidaka; Chiaki Ikejima; Fumio Yamashita; Chiine Kodama; Katsuyoshi Mizukami; Makoto Michikawa; Takashi Asada
Journal:  Am J Geriatr Psychiatry       Date:  2012-07       Impact factor: 4.105

9.  Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study.

Authors:  Olivier Piguet; David A Grayson; Helen Creasey; Hayley P Bennett; William S Brooks; Louise M Waite; G Anthony Broe
Journal:  Neuroepidemiology       Date:  2003 May-Jun       Impact factor: 3.282

10.  Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14 786 middle-aged men and women in Finland.

Authors:  P Jousilahti; E Vartiainen; J Tuomilehto; P Puska
Journal:  Circulation       Date:  1999-03-09       Impact factor: 29.690

View more
  25 in total

1.  Triglycerides Paradox Among the Oldest Old: "The Lower the Better?"

Authors:  Yue-Bin Lv; Chen Mao; Xiang Gao; Zhao-Xue Yin; Virginia Byers Kraus; Jin-Qiu Yuan; Juan Zhang; Jie-Si Luo; Yi Zeng; Xiao-Ming Shi
Journal:  J Am Geriatr Soc       Date:  2019-01-10       Impact factor: 5.562

Review 2.  White matter microstructure and cognitive decline in metabolic syndrome: a review of diffusion tensor imaging.

Authors:  Freddy J Alfaro; Anna Gavrieli; Patricia Saade-Lemus; Vasileios-Arsenios Lioutas; Jagriti Upadhyay; Vera Novak
Journal:  Metabolism       Date:  2017-09-08       Impact factor: 8.694

3.  Sex-specific nonlinear associations between serum lipids and different domains of cognitive function in middle to older age individuals.

Authors:  Yanhui Lu; Yu An; Huanling Yu; Fengyuan Che; Xiaona Zhang; Hongguo Rong; Yuandi Xi; Rong Xiao
Journal:  Metab Brain Dis       Date:  2017-04-03       Impact factor: 3.584

4.  Cognitive Status and Nutritional Markers in a Sample of Institutionalized Elderly People.

Authors:  María Leirós; Elena Amenedo; Marina Rodríguez; Paula Pazo-Álvarez; Luis Franco; Rosaura Leis; Miguel-Ángel Martínez-Olmos; Constantino Arce
Journal:  Front Aging Neurosci       Date:  2022-05-24       Impact factor: 5.702

5.  Associations of Lipid Levels and Cognition: Findings from the Hispanic Community Health Study/Study of Latinos.

Authors:  Melissa Lamar; Ramon A Durazo-Arvizu; Carlos J Rodriguez; Robert C Kaplan; Marisa J Perera; Jianwen Cai; Rebeca A Espinoza Giacinto; Hector M González; Martha L Daviglus
Journal:  J Int Neuropsychol Soc       Date:  2019-09-23       Impact factor: 2.892

6.  Gene discovery for high-density lipoprotein cholesterol level change over time in prospective family studies.

Authors:  Mary F Feitosa; Kathryn L Lunetta; Lihua Wang; Mary K Wojczynski; Candace M Kammerer; Thomas Perls; Nicole Schupf; Kaare Christensen; Joanne M Murabito; Michael A Province
Journal:  Atherosclerosis       Date:  2020-02-14       Impact factor: 5.162

7.  Longitudinal trajectories of metabolic syndrome on different neurocognitive domains: a cohort study from the Taiwan biobank.

Authors:  Shou-En Wu; Wei-Liang Chen
Journal:  Aging (Albany NY)       Date:  2021-06-11       Impact factor: 5.682

8.  Long-Term Increase in Cholesterol Is Associated With Better Cognitive Function: Evidence From a Longitudinal Study.

Authors:  Huamin Liu; Lianwu Zou; Rui Zhou; Minyi Zhang; Shanyuan Gu; Jiazhen Zheng; Daniel Nyarko Hukportie; Keyi Wu; Zhiwei Huang; Zelin Yuan; Xianbo Wu
Journal:  Front Aging Neurosci       Date:  2021-06-17       Impact factor: 5.750

Review 9.  Effects of Plasma Lipids and Statins on Cognitive Function.

Authors:  Rui Li; Tian-Jun Wang; Pei-Yuan Lyu; Yang Liu; Wei-Hong Chen; Ming-Yue Fan; Jing Xu
Journal:  Chin Med J (Engl)       Date:  2018-02-20       Impact factor: 2.628

10.  Investigation of the prevalence of Cognitive Impairment and its risk factors within the elderly population in Shanghai, China.

Authors:  Longbing Ren; Yongtao Zheng; Lezhou Wu; Yijun Gu; Yusheng He; Bo Jiang; Jie Zhang; Lijuan Zhang; Jue Li
Journal:  Sci Rep       Date:  2018-02-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.